PDCD1 and myeloid sarcoma: In this respect, PD-1 expression on T cells from patients with different types of MS was analyzed, and it was revealed that a polymorphism of an intronic +7146G/A of PD-1 didn't affect MS susceptibility, but there was a notable aggravation of ongoing MS.